Arta M Monjazeb

Title(s)Professor in Residence, MED: Radiation-Oncology
SchoolSchool of Medicine
Address4501 X Street, G-120
CA 95817
vCardDownload vCard
    Other Positions
    Title(s)Acting/Interim Department Chair, MED: Radiation-Oncology


    Collapse Research 
    Collapse research activities and funding
    The Impact of Obesity on Radiotherapy Anti-Tumor Effects
    NIH R01CA240751Mar 1, 2022 - Feb 28, 2027
    Role: Principal Investigator
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial. Lancet. 2026 Sep 06. Daly ME, Simone CB, Redman MW, Hsieh MH, Hesketh PJ, Hu C, Monjazeb AM, Steuer CE, Ganti AK, Kashani R, Bauman JR, Feliciano JL, Moon J, Ku K, Le-Lindqwister N, Baschnagel AM, Maraboyina S, Sherwood GB, Almquist D, Higgins KA, Gray JE, Bradley JD, Kelly K. PMID: 42702214.
      View in: PubMed   Mentions:
    2. A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer. Oncoimmunology. 2026 Dec 31; 15(1):2695491. Wang CX, Luxardi G, Mori H, Maverakis EM, Merleev AA, Marusina AI, Borowsky AD, Parikh M, Riess JW, Moshiri A, Bazhenova L, Gubens M, Koczywas M, Butner JD, Huang J, Kim SK, Vick LV, Sun Y, Canter RJ, Murphy WJ, Daly ME, Kelly K, Monjazeb AM. PMID: 42684015; PMCID: PMC13540112.
      View in: PubMed   Mentions:
    3. Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model. Blood Adv. 2026 Aug 07. Firoz WA, Sheng MK, Ruivo P, Vick LV, Collins CP, Nielsen RN, Shah RK, Khuat LT, Xiong Y, Dave M, Judge SJ, Canter RJ, Monjazeb AM, Blazar BR, Zamora AE, Murphy WJ. PMID: 42566762.
      View in: PubMed   Mentions:    Fields:    
    4. Intrinsic tumor cell line immunogenicity may drive CAR-independent T cell responses and confound CAR T cell preclinical modeling. J Immunother Cancer. 2026 Jul 23; 14(7). Sheng MK, Firoz WA, Loi K, Vick LV, Collins CP, Nielsen RN, Schmeling JL, Gulati S, Judge SJ, Canter RJ, Monjazeb AM, Zamora AE, Murphy WJ. PMID: 42493214; PMCID: PMC13404409.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Intratumoral TIGIT blockade augments antitumor responses and bypasses increased functionality of peripheral TIGIT+ NK cells in mouse and human models of bone and soft tissue sarcoma. J Immunother Cancer. 2026 Jul 22; 14(7). Lammers ML, Sholevar CJ, Karimzadeh M, Razmara AM, Cruz SM, Purl MC, Liu NM, Bakke D, Plagens RN, Elliott A, Sheng MK, Dongen CV, Tran T, Trinh AT, Nielsen RN, Kotamraju T, Farley LE, Iranpur KR, Mukarrama T, Gronchi A, Riedel RF, Monjazeb AM, Thorpe SW, Darrow MA, Kim J, Murphy WJ, Judge SJ, Canter RJ. PMID: 42486610; PMCID: PMC13404423.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    6. Age-driven shifts in T and NK cell responses amplify inflammation and coagulopathy during viral infection in mice and humans. Front Immunol. 2026; 17:1712726. Collins CP, Dunai C, Vick LV, Khuat LT, Merleev A, Choi EA, Lam J, Maverakis E, Monjazeb AM, Longo DL, Baumgarth N, Canter RJ, Murphy WJ. PMID: 41737204; PMCID: PMC12926148.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference. Oncoimmunology. 2025 Dec; 14(1):2507856. Talebi F, Gregucci F, Ahmed J, Ben Chetrit N, D Brown B, Chan TA, Chand D, Constanzo J, Demaria S, I Gabrilovich D, Golden E, Godkin A, Guha C, P Gupta G, Hasan A, G Herrera F, Kaufman H, Li D, A Melcher A, McDonald S, Merghoub T, Monjazeb AM, Paris S, Pitroda S, Sadanandam A, Schaue D, Santambrogio L, Szapary P, Sage J, W Welsh J, Wilkins A, H Young K, Wennerberg E, Zitvogel L, Galluzzi L, Deutsch E, C Formenti S. PMID: 40401900; PMCID: PMC12101595.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    8. Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. Lancet Oncol. 2025 Mar; 26(3):e152-e170. Morris ZS, Demaria S, Monjazeb AM, Formenti SC, Weichselbaum RR, Welsh J, Enderling H, Schoenfeld JD, Brody JD, McGee HM, Mondini M, Kent MS, Young KH, Galluzzi L, Karam SD, Theelen WSME, Chang JY, Huynh MA, Daib A, Pitroda S, Chung C, Serre R, Grassberger C, Deng J, Sodji QH, Nguyen AT, Patel RB, Krebs S, Kalbasi A, Kerr C, Vanpouille-Box C, Vick L, Aguilera TA, Ong IM, Herrera F, Menon H, Smart D, Ahmed J, Gartrell RD, Roland CL, Fekrmandi F, Chakraborty B, Bent EH, Berg TJ, Hutson A, Khleif S, Sikora AG, Fong L. PMID: 40049206; PMCID: PMC12758888.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    9. A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations. JTO Clin Res Rep. 2025 Jun; 6(6):100806. Riess JW, Lara MS, Luxardi G, Lopez de Rodas M, Shimoda M, Kelly K, Lara PN, Beckett L, Monjazeb A, Schalper KA, Maverakis E, Gandara DR. PMID: 40486486; PMCID: PMC12145753.
      View in: PubMed   Mentions:
    10. Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO). Lancet Oncol. 2024 10; 25(10):e489-e500. Zumsteg ZS, Sheth S, Jabbour SK, Patel KR, Kimple RJ, Williams TM, Xu-Welliver M, Torres-Saavedra PA, Monjazeb AM, Mayadev J, Finkelstein SE, Buatti JM, Patel SP, Lin SH. PMID: 39362260; PMCID: PMC11778933.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    11. Potential roles of sex-linked differences in obesity and cancer immunotherapy: revisiting the obesity paradox. NPJ Metab Health Dis. 2024; 2(1):5. Vick LV, Rosario S, Riess JW, Canter RJ, Mukherjee S, Monjazeb AM, Murphy WJ. PMID: 38800540; PMCID: PMC11116109.
      View in: PubMed   Mentions: 6  
    12. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas. Front Immunol. 2022; 13:893177. Judge SJ, Bloomstein JD, Sholevar CJ, Darrow MA, Stoffel KM, Vick LV, Dunai C, Cruz SM, Razmara AM, Monjazeb AM, Rebhun RB, Murphy WJ, Canter RJ. PMID: 35874727; PMCID: PMC9300876.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    13. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat Commun. 2022 03 21; 13(1):1511. Jiang N, Xie B, Xiao W, Fan M, Xu S, Duan Y, Hamsafar Y, Evans AC, Huang J, Zhou W, Lin X, Ye N, Wanggou S, Chen W, Jing D, Fragoso RC, Dugger BN, Wilson PF, Coleman MA, Xia S, Li X, Sun LQ, Monjazeb AM, Wang A, Murphy WJ, Kung HJ, Lam KS, Chen HW, Li JJ. PMID: 35314680; PMCID: PMC8938495.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansAnimalsCells
    14. Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 2021 12 16; 138(24):2583-2588. Khuat LT, Vick LV, Dunai C, Collins CP, More SK, Le CT, Pai CS, Stoffel KM, Maverakis E, Canter RJ, Monjazeb AM, Longo DL, Abedi M, Choi E, Blazar BR, Dave M, Murphy WJ. PMID: 34424962; PMCID: PMC8678998.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    15. T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma. Front Vet Sci. 2021; 8:772932. Sparger EE, Chang H, Chin N, Rebhun RB, Withers SS, Kieu H, Canter RJ, Monjazeb AM, Kent MS. PMID: 34926643; PMCID: PMC8674490.
      View in: PubMed   Mentions: 7  
    16. Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice. Front Immunol. 2021; 12:752484. Khuat LT, Vick LV, Choi E, Dunai C, Merleev AA, Maverakis E, Blazar BR, Monjazeb AM, Murphy WJ. PMID: 34707616; PMCID: PMC8542879.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    17. Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas. J Immunother Cancer. 2020 11; 8(2). Judge SJ, Darrow MA, Thorpe SW, Gingrich AA, O'Donnell EF, Bellini AR, Sturgill IR, Vick LV, Dunai C, Stoffel KM, Lyu Y, Chen S, Cho M, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 33158916; PMCID: PMC7651745.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    18. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591. Candas-Green D, Xie B, Huang J, Fan M, Wang A, Menaa C, Zhang Y, Zhang L, Jing D, Azghadi S, Zhou W, Liu L, Jiang N, Li T, Gao T, Sweeney C, Shen R, Lin TY, Pan CX, Ozpiskin OM, Woloschak G, Grdina DJ, Vaughan AT, Wang JM, Xia S, Monjazeb AM, Murphy WJ, Sun LQ, Chen HW, Lam KS, Weichselbaum RR, Li JJ. PMID: 32929084; PMCID: PMC7490264.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimalsCells
    19. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. J Clin Invest. 2020 06 01; 130(6):3051-3068. Judge SJ, Dunai C, Aguilar EG, Vick SC, Sturgill IR, Khuat LT, Stoffel KM, Van Dyke J, Longo DL, Darrow MA, Anderson SK, Blazar BR, Monjazeb AM, Serody JS, Canter RJ, Murphy WJ. PMID: 32134744; PMCID: PMC7260004.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    20. Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer. PLoS One. 2020; 15(2):e0224775. Judge SJ, Yanagisawa M, Sturgill IR, Bateni SB, Gingrich AA, Foltz JA, Lee DA, Modiano JF, Monjazeb AM, Culp WTN, Rebhun RB, Murphy WJ, Kent MS, Canter RJ. PMID: 32084139; PMCID: PMC7034869.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    21. Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):e372-e377. Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. PMID: 31866577.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden. Clin Colorectal Cancer. 2019 12; 18(4):307-309. Gong J, Robertson MD, Kim E, Fakih M, Schrock AB, Tam KW, Burugapalli B, Monjazeb AM, Hendifar AE, Hitchins M, Klempner SJ, Cho M. PMID: 31563511.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    23. The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer. Front Immunol. 2019; 10:1940. Naik A, Monjazeb AM, Decock J. PMID: 31475003; PMCID: PMC6703078.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    24. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis. J Surg Oncol. 2019 Sep; 120(4):753-760. Judge SJ, Lata-Arias K, Yanagisawa M, Darrow MA, Monjazeb AM, Kirane AR, Bold RJ, Canter RJ, Canter DJ. PMID: 31355444.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Prospective, Randomized Control Trial Investigating the Impact of a Physician-Communicated Radiation Therapy Plan Review on Breast Cancer Patient-Reported Satisfaction. Pract Radiat Oncol. 2019 Nov; 9(6):e487-e496. Dyer BA, Li CS, Daly ME, Monjazeb AM, Mayadev JS. PMID: 31226443.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    26. Role of Radiation Therapy in Adult Extraskeletal Ewing's Sarcoma Patients Treated with Chemotherapy and Surgery. Sarcoma. 2019; 2019:5413527. Saiz AM, Gingrich AA, Canter RJ, Kirane AR, Monjazeb AM, Randall RL, Thorpe SW. PMID: 31178655; PMCID: PMC6507246.
      View in: PubMed   Mentions: 3  
    27. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer. Cancer. 2019 08 15; 125(16):2732-2746. George TJ, Franke AJ, Chakravarthy AB, Das P, Dasari A, El-Rayes BF, Hong TS, Kinsella TJ, Landry JC, Lee JJ, Monjazeb AM, Jacobs SA, Raben D, Rahma OE, Williams TM, Wu C, Coleman CN, Vikram B, Ahmed MM. PMID: 31017664; PMCID: PMC6663584.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    28. Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population? J Surg Oncol. 2019 Jun; 119(8):1087-1098. Gingrich AA, Bateni SB, Monjazeb AM, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. PMID: 30977916.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    29. Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma. Vet Comp Oncol. 2019 Sep; 17(3):242-252. Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. PMID: 30684301; PMCID: PMC6658355.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    30. The complicated effects of  obesity on cancer and immunotherapy. Immunotherapy. 2019 01; 11(1):11-14. Wang Z, Monjazeb AM, Murphy WJ. PMID: 30702013.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    31. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors. Pract Radiat Oncol. 2019 Mar; 9(2):e196-e202. Nguyen KNB, Hause DJ, Novak J, Monjazeb AM, Daly ME. PMID: 30496842; PMCID: PMC6402805.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    32. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019 01; 25(1):141-151. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. PMID: 30420753; PMCID: PMC6324991.
      View in: PubMed   Mentions: 545     Fields:    Translation:HumansAnimalsCells
    33. Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma. Vet Comp Oncol. 2019 Mar; 17(1):49-60. Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. PMID: 30156029; PMCID: PMC6363827.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    34. Distinct immune signatures in directly treated and distant tumors result from TLR adjuvants and focal ablation. Theranostics. 2018; 8(13):3611-3628. Chavez M, Silvestrini MT, Ingham ES, Fite BZ, Mahakian LM, Tam SM, Ilovitsh A, Monjazeb AM, Murphy WJ, Hubbard NE, Davis RR, Tepper CG, Borowsky AD, Ferrara KW. PMID: 30026870; PMCID: PMC6037035.
      View in: PubMed   Mentions: 55     Fields:    Translation:Animals
    35. Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs. Dev Comp Immunol. 2018 10; 87:64-74. Withers SS, Moore PF, Chang H, Choi JW, McSorley SJ, Kent MS, Monjazeb AM, Canter RJ, Murphy WJ, Sparger EE, Rebhun RB. PMID: 29859828; PMCID: PMC6197816.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    36. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1259-1270. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM. PMID: 29891204; PMCID: PMC6364565.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    37. Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. Anticancer Res. 2018 03; 38(3):1491-1497. Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ. PMID: 29491077; PMCID: PMC5836802.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    38. Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. J Immunother Cancer. 2018 01 29; 6(1):6. Marciscano AE, Walker JM, McGee HM, Kim MM, Kunos CA, Monjazeb AM, Shiao SL, Tran PT, Ahmed MM. PMID: 29375032; PMCID: PMC5787916.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    39. T Cells Dominate the Local Immune Response Induced by Intralesional IL-2 in Combination with Imiquimod and Retinoid for In-Transit Metastatic Melanoma. J Invest Dermatol. 2018 06; 138(6):1442-1445. Ogawa H, Luxardi G, Kirane A, Kulkarni R, Monjazeb AM, Cheng MY, Ma C, Maverakis E. PMID: 29291382.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    40. Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas. J Surg Res. 2018 03; 223:207-214. Henderson T, Chen M, Darrow MA, Li CS, Chiu CL, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 29433875; PMCID: PMC5812363.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    41. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. J Immunother Cancer. 2017 Dec 19; 5(1):98. Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy WJ. PMID: 29254507; PMCID: PMC5735903.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    42. From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely. Clin Cancer Res. 2017 09 01; 23(17):4980-4991. Day D, Monjazeb AM, Sharon E, Ivy SP, Rubin EH, Rosner GL, Butler MO. PMID: 28864726; PMCID: PMC5736967.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. The Challenge for Development of Valuable Immuno-oncology Biomarkers. Clin Cancer Res. 2017 09 01; 23(17):4970-4979. Mehnert JM, Monjazeb AM, Beerthuijzen JMT, Collyar D, Rubinstein L, Harris LN. PMID: 28864725; PMCID: PMC5657536.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    44. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis. Ann Surg Oncol. 2017 Oct; 24(11):3252-3263. Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. PMID: 28741123; PMCID: PMC5693726.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    45. Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):362-373. Baird JR, Monjazeb AM, Shah O, McGee H, Murphy WJ, Crittenden MR, Gough MJ. PMID: 28871985; PMCID: PMC5604475.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    46. Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy. J Immunother Cancer. 2017; 5:33. Sckisel GD, Mirsoian A, Minnar CM, Crittenden M, Curti B, Chen JQ, Blazar BR, Borowsky AD, Monjazeb AM, Murphy WJ. PMID: 28428882; PMCID: PMC5394626.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    47. Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols. JCI Insight. 2017 03 23; 2(6):e90521. Silvestrini MT, Ingham ES, Mahakian LM, Kheirolomoom A, Liu Y, Fite BZ, Tam SM, Tucci ST, Watson KD, Wong AW, Monjazeb AM, Hubbard NE, Murphy WJ, Borowsky AD, Ferrara KW. PMID: 28352658; PMCID: PMC5358490.
      View in: PubMed   Mentions: 65     Fields:    Translation:AnimalsCells
    48. Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer. 2016; 4:97. Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. PMID: 28031824; PMCID: PMC5171656.
      View in: PubMed   Mentions: 81     Fields:    
    49. Conservative management of desmoid tumors is safe and effective. J Surg Res. 2016 09; 205(1):115-20. Park JS, Nakache YP, Katz J, Boutin RD, Steffner RJ, Monjazeb AM, Canter RJ. PMID: 27621007.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    50. The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning. Anticancer Res. 2016 Jun; 36(6):3013-7. Miyamoto J, Michaud AL, Harandi NK, Kim EJ, Semrad T, Khatri V, Mayadev J, Perks J, Monjazeb AM. PMID: 27272819.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. Older Age Modifies Oncologic Outcome Following Radiotherapy in Soft-tissue Sarcoma: A Subtype-specific SEER Analysis. Anticancer Res. 2016 Apr; 36(4):1745-50. Yuen NK, Li CS, Monjazeb AM, Borys D, Bold RJ, Canter RJ. PMID: 27069154.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res. 2016 Sep 01; 22(17):4328-40. Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy WJ. PMID: 26979392; PMCID: PMC5010514.
      View in: PubMed   Mentions: 67     Fields:    Translation:AnimalsCells
    53. Radiation dose and checkpoint blockade immunotherapy: unanswered questions. Lancet Oncol. 2016 Jan; 17(1):e3-4. Monjazeb AM, Schoenfeld JD. PMID: 26758758.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    54. Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma. Cureus. 2015 Dec 15; 7(12):e406. Dyer BA, Kahn LA, Matin M, Bold RJ, Tanaka MI, Monjazeb AM. PMID: 26824007; PMCID: PMC4725616.
      View in: PubMed   Mentions:
    55. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer. J Thorac Oncol. 2015 Dec; 10(12):1685-93. Daly ME, Monjazeb AM, Kelly K. PMID: 26484629.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    56. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015 Oct 15; 195(8):4010-9. Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ. PMID: 26363055; PMCID: PMC4781667.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansAnimalsCells
    57. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016 Feb; 5(2):e1075114. Mall C, Sckisel GD, Proia DA, Mirsoian A, Grossenbacher SK, Pai CS, Chen M, Monjazeb AM, Kelly K, Blazar BR, Murphy WJ. PMID: 27057446; PMCID: PMC4801432.
      View in: PubMed   Mentions: 36     Fields:    
    58. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. J Am Acad Dermatol. 2015 Oct; 73(4):645-54. Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. PMID: 26259990.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    59. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 2015 Aug 18; 43(2):240-50. Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, Wiltrout RH, Murphy WJ. PMID: 26231116; PMCID: PMC4770886.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    60. Older age impacts radiotherapy-related outcomes in soft tissue sarcoma. J Surg Res. 2015 Dec; 199(2):494-504. Yuen NK, Li CS, Monjazeb AM, Borys D, Bold RJ, Canter RJ. PMID: 26163324; PMCID: PMC4789295.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells. Oncoimmunology. 2015 Sep; 4(9):e1036212. Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy WJ. PMID: 26405602; PMCID: PMC4570100.
      View in: PubMed   Mentions: 52     Fields:    
    62. Anthropomorphic Phantoms for Confirmation of Linear Accelerator-Based Small Animal Irradiation. Cureus. 2015 Mar; 7(3):e254. Perks JR, Lucero S, Monjazeb AM, Li JJ. PMID: 26180678; PMCID: PMC4494576.
      View in: PubMed   Mentions: 6  
    63. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med. 2014 Nov 17; 211(12):2373-83. Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai CC, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy WJ. PMID: 25366964; PMCID: PMC4235633.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimalsCells
    64. Combining targeted agents with modern radiotherapy in soft tissue sarcomas. J Natl Cancer Inst. 2014 Nov; 106(11). Wong P, Houghton P, Kirsch DG, Finkelstein SE, Monjazeb AM, Xu-Welliver M, Dicker AP, Ahmed M, Vikram B, Teicher BA, Coleman CN, Machtay M, Curran WJ, Wang D. PMID: 25326640; PMCID: PMC4207861.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    65. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. BMC Cancer. 2014 Oct 10; 14:756. Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ. PMID: 25301268; PMCID: PMC4200119.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    66. Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis. J Surg Oncol. 2015 Feb; 111(2):158-64. Naing KW, Monjazeb AM, Li CS, Lee LY, Yang A, Borys D, Canter RJ. PMID: 25176165; PMCID: PMC4305005.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    67. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help. PLoS One. 2014; 9(8):e102709. Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy WJ. PMID: 25119341; PMCID: PMC4131875.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    68. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. PMID: 25064746; PMCID: PMC4254314.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    69. Antitumor effects of cisplatin combined with tecemotide immunotherapy in a human MUC1 transgenic lung cancer mouse model. Cancer Immunol Res. 2014 Jun; 2(6):581-9. Kao CJ, Wurz GT, Monjazeb AM, Vang DP, Cadman TB, Griffey SM, Wolf M, DeGregorio MW. PMID: 24894093.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    70. Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2014 May; 21(5):1616-23. Canter RJ, Borys D, Olusanya A, Li CS, Lee LY, Boutin RD, Christensen SD, Tamurian RM, Monjazeb AM. PMID: 24554062; PMCID: PMC4153793.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    71. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med. 2013 Oct 21; 210(11):2223-37. Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ. PMID: 24081947; PMCID: PMC3804937.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansAnimalsCells
    72. Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies. Front Oncol. 2013; 3:197. Monjazeb AM, Zamora AE, Grossenbacher SK, Mirsoian A, Sckisel GD, Murphy WJ. PMID: 23898464; PMCID: PMC3724213.
      View in: PubMed   Mentions: 25  
    73. Influence of physician specialty on treatment recommendations in the multidisciplinary management of soft tissue sarcoma of the extremities. JAMA Surg. 2013 Jul; 148(7):632-9. Wasif N, Smith CA, Tamurian RM, Christensen SD, Monjazeb AM, Martinez SR, Canter RJ. PMID: 23552630.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    74. The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications. Semin Radiat Oncol. 2013 Jan; 23(1):60-73. Monjazeb AM, Blackstock AW. PMID: 23207048.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    75. Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses. PLoS One. 2012; 7(10):e48049. Bouchlaka MN, Sckisel GD, Wilkins D, Maverakis E, Monjazeb AM, Fung M, Welniak L, Redelman D, Fuchs A, Evrensel CA, Murphy WJ. PMID: 23133545; PMCID: PMC3485005.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    76. Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. Anticancer Res. 2012 Sep; 32(9):3911-5. Shah D, Borys D, Martinez SR, Li CS, Tamurian RM, Bold RJ, Monjazeb A, Canter RJ. PMID: 22993336; PMCID: PMC4153787.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    77. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. J Immunotoxicol. 2012 Jul-Sep; 9(3):248-58. Monjazeb AM, Hsiao HH, Sckisel GD, Murphy WJ. PMID: 22734880.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    78. The role of chemoradiation for patients with resectable or potentially resectable pancreatic cancer. Expert Rev Anticancer Ther. 2012 Apr; 12(4):469-80. Kimple RJ, Russo S, Monjazeb A, Blackstock AW. PMID: 22500684; PMCID: PMC3628691.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    79. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiation-induced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):376-82. Yi SK, Mak W, Yang CC, Liu T, Cui J, Chen AM, Purdy JA, Monjazeb AM, Do L. PMID: 22342301.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    80. Treatment of hemoptysis associated with aspergilloma using external beam radiotherapy: A case report and literature review. Pract Radiat Oncol. 2011 Oct-Dec; 1(4):279-81. Samuelian JM, Attia AA, Jensen CA, Monjazeb AM, Blackstock AW. PMID: 24674006.
      View in: PubMed   Mentions: 4     Fields:    
    81. A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):743-8. Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG. PMID: 21236604; PMCID: PMC4586107.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    82. Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection? J Clin Oncol. 2010 Nov 01; 28(31):4714-21. Monjazeb AM, Riedlinger G, Aklilu M, Geisinger KR, Mishra G, Isom S, Clark P, Levine EA, Blackstock AW. PMID: 20876421; PMCID: PMC3020701.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    83. Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. BMC Cancer. 2010 Mar 31; 10:121. Sanders AM, Stehle JR, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z. PMID: 20356394; PMCID: PMC2861034.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    84. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer. Clin Adv Hematol Oncol. 2009 May; 7(5):327-333, 342. Kim C, Monjazeb AM, Suntharalingam M, Giesinger KR, Blackstock AW. PMID: 19521322.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis. 2006 Oct; 27(10):1950-60. Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH. PMID: 16704987.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    86. Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins Leukot Essent Fatty Acids. 2005 Dec; 73(6):463-74. Monjazeb AM, High KP, Koumenis C, Chilton FH. PMID: 16169197.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    87. Intussusception secondary to metastasis from a low-grade retroperitoneal liposarcoma. Am Surg. 2004 Sep; 70(9):775-8. Monjazeb A, Stanton C, Levine EA. PMID: 15481292.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    88. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. J Lipid Res. 2002 Nov; 43(11):1818-28. Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. PMID: 12401880.
      View in: PubMed   Mentions: 34     Fields:    Translation:Cells
    89. Antineoplastic properties of arachidonic acid and its metabolites. Prostaglandins Leukot Essent Fatty Acids. 2002 Jan; 66(1):5-12. Monjazeb AM, Clay CE, High KP, Chilton FH. PMID: 12051952.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    Arta's Networks
    Concepts (383)
    Derived automatically from this person's publications.
    _
    Co-Authors (79)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _